Leila Alland

Follow
Get notifications in MyBN when activity occurs.
Subscribe to BN Log In
Leila Alland
Non-Executive Director / Radiopharm Theranostics

Dr Alland is a pediatric hematologist-oncologist with a record in developing oncology drug products. She has held positions at AstraZeneca, Bristol-Myers Squibb, Novartis and Schering-Plough, where she contributed to multiple drug approvals. Dr Alland is currently Chief Medical Officer of PMV Pharmaceuticals, a clinical stage precision oncology company. During her academic tenure, she was awarded the James S McDonnell Foundation Scholar Award and pursued basic cancer research while also caring for children with cancer and blood disorders. Her Other current directorship is with Abeona Therapeutics Inc (NASDAQ: ABEO) since April 2021. She is a member of risk committee.

Lists and Charts

Roles

2022
Non-Executive Director
Radiopharm Theranostics
Year started and most recent title

Total Shareholder Return as at 02/12/24

Rank Company 1 Yr 5 Yr
1630th Beam Communications Holdings -61.55% -23.17%
1631st Leeuwin Metals -61.59% 0%
1632nd Radiopharm Theranostics -61.68% 0%
1633rd Novatti Group -61.9% -31.99%
1634th Andromeda Metals -61.93% -29.84%
View Full List
1767 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Person Activity

 NEW ROLE: Non-Executive Director, Radiopharm Theranostics 07 Aug 2024

Related Information

Access to our data for Leila Alland is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

Leila Alland is linked to 1 organisation which is included in 1 list - Public Companies - non WA.

To see the data you will need to Subscribe.

X